Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Cardiovascular safety of phosphodiesterase inhibitors for treating erectile dysfunction in elderly men

Este protocolo ha sido retirado

ver el histórico de versiones

Información

DOI:
https://doi.org/10.1002/14651858.CD011178.pub2Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 06 marzo 2017see what's new
Tipo:
  1. Intervention
Etapa:
  1. Protocol
Grupo Editorial Cochrane:

  1. Grupo Cochrane de Corazón

Copyright:
  1. Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • Rende Xu

    Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai, China

  • Ben He

    Correspondencia a: Department of Cardiology, Shanghai Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China

    [email protected]

  • Jun Pu

    Department of Cardiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

  • Karen Peterson

    Department of Cardiovascular Disease, Mayo Clinic, Rochester, USA

Version history

Published

Title

Stage

Authors

Version

2017 Mar 06

Cardiovascular safety of phosphodiesterase inhibitors for treating erectile dysfunction in elderly men

Protocol

Rende Xu, Ben He, Jun Pu, Karen Peterson

https://doi.org/10.1002/14651858.CD011178.pub2

2014 Jun 25

Cardiovascular safety of phosphodiesterase inhibitors for treating erectile dysfunction in elderly men

Protocol

Rende Xu, Ben He, Jun Pu, Karen Peterson

https://doi.org/10.1002/14651858.CD011178